Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (271-280 of 544) with videos related to

Pageof 55
Sort By:
The Lancet. Diabetes & Endocrinology|May 12, 2016
Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort studyChristopher J D Wallis, Kirk Lo, Yuna Lee, et al.
BMC Cancer|June 28, 2019
Predictors of mammographic density among women with a strong family history of breast cancerOlivia Moran, Andrea Eisen, Rochelle Demsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detectionRobert K Nam, William W Zhang, John Trachtenberg, et al.
Breast Cancer Research and Treatment|August 10, 2006
A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in PolandCezary Cybulski, Dominika Wokołorczyk, Tomasz Huzarski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
Epistatic relationship between the cancer susceptibility genes CHEK2 and p27Cezary Cybulski, Bartłomiej Gliniewicz, Andrzej Sikorski, et al.
Breast Cancer Research and Treatment|November 11, 2020
The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancerKelly A Metcalfe, Alexandra Candib, Vasily Giannakeas, et al.
Gynecologic Oncology|September 3, 2005
Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Susan L Neuhausen, et al.
The Journal of Urology|March 7, 2006
A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosisRobert K Nam, Jonathan R Reeves, Ants Toi, et al.
International Journal of Cancer|March 30, 2006
Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of IranMohammad Reza Akbari, Reza Malekzadeh, Dariush Nasrollahzadeh, et al.
Familial Cancer|January 9, 2013
The risk of gastric cancer in carriers of CHEK2 mutationsUrszula Teodorczyk, Cezary Cybulski, Dominika Wokołorczyk, et al.
Pageof 55

Showing results (271-280 of 544) with videos related to

Sort By:
Pageof 55
The Lancet. Diabetes & Endocrinology|May 12, 2016
Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort studyChristopher J D Wallis, Kirk Lo, Yuna Lee, et al.
BMC Cancer|June 28, 2019
Predictors of mammographic density among women with a strong family history of breast cancerOlivia Moran, Andrea Eisen, Rochelle Demsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detectionRobert K Nam, William W Zhang, John Trachtenberg, et al.
Breast Cancer Research and Treatment|August 10, 2006
A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in PolandCezary Cybulski, Dominika Wokołorczyk, Tomasz Huzarski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
Epistatic relationship between the cancer susceptibility genes CHEK2 and p27Cezary Cybulski, Bartłomiej Gliniewicz, Andrzej Sikorski, et al.
Breast Cancer Research and Treatment|November 11, 2020
The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancerKelly A Metcalfe, Alexandra Candib, Vasily Giannakeas, et al.
Gynecologic Oncology|September 3, 2005
Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Susan L Neuhausen, et al.
The Journal of Urology|March 7, 2006
A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosisRobert K Nam, Jonathan R Reeves, Ants Toi, et al.
International Journal of Cancer|March 30, 2006
Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of IranMohammad Reza Akbari, Reza Malekzadeh, Dariush Nasrollahzadeh, et al.
Familial Cancer|January 9, 2013
The risk of gastric cancer in carriers of CHEK2 mutationsUrszula Teodorczyk, Cezary Cybulski, Dominika Wokołorczyk, et al.
Pageof 55